Aspirex (DT-0111)
/ Danmir Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 25, 2023
DT-0111: a novel P2X3 receptor antagonist.
(PubMed, Purinergic Signal)
- "Currently, several P2X3R and P2X2/3R antagonists are being developed as drug-candidates for the treatment of chronic cough. This report presents the receptor affinity data of a novel water-soluble small molecule, DT-0111, that acts as a selective P2X3R antagonist."
Journal • Asthma • Chronic Cough • Chronic Obstructive Pulmonary Disease • Cough • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1